Baiyang Pharmaceutical announced that Baiyang Health Industry International Trading Co., Ltd., a wholly-owned subsidiary, plans to exercise a share warrant right to subscribe for 15.214,400 E-1 series preferred shares issued by Zap Medical at the exercise price of US$0.723 per share, with a total investment amount of approximately US$11 million. After the investment was completed, the company indirectly held a total of 20.86% of Zap Medical's shares. This transaction will not result in a change in the scope of the company's consolidated statements.

Baiyang Pharmaceutical announced that Baiyang Health Industry International Trading Co., Ltd., a wholly-owned subsidiary, plans to exercise a share warrant right to subscribe for 15.214,400 E-1 series preferred shares issued by Zap Medical at the exercise price of US$0.723 per share, with a total investment amount of approximately US$11 million. After the investment was completed, the company indirectly held a total of 20.86% of Zap Medical's shares. This transaction will not result in a change in the scope of the company's consolidated statements.